Global cellular response to chemotherapy-induced apoptosis

Area of Science:

• Molecular Biology
• Cancer Research
• Cell Biology

Background:

• Understanding cancer cell response to chemotherapy is crucial for effective cancer treatment.
• The precise molecular mechanisms by which cancer cells cope with chemotherapeutic agents before apoptosis remain largely unelucidated.

Purpose of the Study:

• To investigate the integrated systems-level dynamics of transcription, translation, and proteolysis in cancer cells under chemotherapeutic stress.
• To elucidate the mechanisms of resistance and cell death pathways in myeloma cells treated with bortezomib.

Main Methods:

• Integrated systems-level analysis of transcription, translation, and proteolysis.
• Quantitative proteomics and ribosome profiling in bortezomib-treated myeloma cells.
• Investigation of caspase-dependent and independent proteolytic events.

Main Results:

• Chemotherapy (bortezomib) induces global translation inhibition but limited production of anti-apoptotic proteins.
• Translational regulation of stress response genes was observed.
• Apoptosis involves caspase-dependent and independent proteolysis, largely unaffected by upstream drug effects.
• Co-targeting heat shock factor 1 (HSF1) enhances bortezomib-induced cell death.

Conclusions:

• Cancer cells exhibit complex resistance mechanisms involving translational control and specific protein degradation pathways.
• Targeting HSF1 alongside proteasome inhibitors presents a potential strategy to overcome chemotherapy resistance.
• This integrated systems approach provides critical insights into apoptotic dynamics for preclinical anti-cancer drug evaluation.